23andMe Co-Founder Anne Wojcicki talks about the intense scrutiny that her company received from regulators when its DNA testing kits debuted. The fact that they were sold directly to consumers raised the most controversy, just as birth-control tests once did, according to Wojcicki. The Federal Drug Administration’s warning, she says, was an encouraging sign: “To really drive change, you have to change the system.”